Workers’ Comprehensive

News and views in workers’ comp
Important news in workers’ comp delivered to your inbox
Subscribe

Search Workers' Comprehensive Articles

  • Reset
Medmonitor
FDA Approves Hulio for Rheumatoid Arthritis and More

Subcutaneous injections of the new biologic, adalimumab-fkjp, were approved for seven indications.

Read More →
This Month's Must Read
A New Routine: The Growth of Complex Claims and How to Manage Them

Strategies for anticipating and mitigating complex claim risks.

Read More →
Clinical Insights
American Medical Association Asks CDC to Revise Opioid Guidelines

The AMA suggests that prescription medications are no longer a significant factor in the opioid epidemic, and that opioid prescription limits should change.

Read More →
Legislation & Policy
States Pass COVID-19 Liability Limitations

Arkansas and Louisiana enacted policies to protect businesses from civil liability stemming from COVID-19 exposure.

Read More →
Industry Trends
WCRI Reports on Interstate Variation Trends in Drug Payments

Data from 28 states years found that NSAIDs and dermatological agents are seeing growth in spending.

Read More →
This Month's Must Read
Growing Pains: The Shift from Opioids to Other Pain Therapies

With opioid utilization decreasing, what concerns do other pain therapies pose?

Read More →
Clinical Insights
WCRI Publishes Medical Price Index

With data from 36 states across 12 years, this report highlights the differences in prices paid for medical services across the nation.

Read More →
Legislation & Policy
Washington Issues Guidelines on COVID-19 Masks for Workers

Occupations are divided into risk categories where each category must utilize appropriate face coverings, masks, or respirators.

Read More →
COVID-19 Developments
Employee Stress and Mental Health When Returning to Work

The National Safety Council discusses managing employee anxiety stemming from COVID-19 when returning to work.

Read More →
Medmonitor
FDA Approves Elyxyb Oral Solution for Migraines

Elyxyb (celecoxib) is an NSAID for the acute treatment of migraine with or without aura.

Read More →
This Month's Must Read
Live Better, Heal Better: Employee Wellness in Workers' Comp

How comorbidities, fatigue, and mental health impact claims management.

Read More →
Clinical Insights
Remdesivir a Potential Treatment for COVID-19?

The FDA allows emergency use in response to positive trials, but more research is needed.

Read More →
COVID-19 Developments
IQVIA Reports on Healthcare Shifts in the COVID-19 Era

A new study explores patients’ use of health services, the impact on medicine use, research activity, and more.

Read More →
Legislation & Policy
California Executive Order Greatly Expands COVID-19 Presumption

Many states expanded workers’ comp for COVID-19, but California casts a wider net.

Read More →
Medmonitor
COVID-19 Updates from the FDA

New developments with diagnostic testing and the use of chloroquine and hydroxychloroquine.

Read More →
This Month's Must Read
Sandy Shtab: Regulatory Acceleration in Response to COVID-19

Healthesystems’ AVP of Advocacy & Compliance discusses regulatory action related to COVID-19 with WorkCompWire.

Read More →
Clinical Insights
Could Convalescent Plasma Treat COVID-19?

The FDA, JAMA, and others think blood from those who recovered from COVID-19 could benefit those with the illness.

Read More →
Legislation & Policy
More States Make COVID-19 Compensable in Workers’ Comp

With frontline workers at risk, states are expanding coverage to healthcare workers, first responders, and other frontline workers.

Read More →
Healthe Developments
Silvia Sacalis: 3 Evolving Clinical Trends in Workers’ Comp

Healthesystems’ VP of Clinical Services discusses population trends, non-opioid pain therapies, and comorbidities with WorkCompWire.

Read More →
COVID-19 Developments
Keep Track of COVID-19 Developments

Healthesystems has created a developments webpage to track updates impacting workers’ comp.

Read More →
Medmonitor
FDA Approves Two Migraine Drugs and Two NSAIDs

Anjeso and a new Advil formulation target pain, while Nurtec™ and Vyepti™ target migraines.

Read More →
This Month's Must Read
2020 Workers’ Comp Industry Insights Survey

Healthesystems collaborated with Risk & Insurance to survey 669 workers’ comp professionals on top trends and challenges.

Read More →
Clinical Insights
JAMA Compares Effectiveness of Treatment Pathways for Opioid Use Disorder

A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.

Read More →
Legislation & Policy
Embracing Telehealth in Reaction to COVID-19

Several state workers’ comp programs are relaxing telehealth rules to promote social distancing.

Read More →
Healthe Developments
Sandy Shtab Featured in IAIABC Member Spotlight

Healthesystems’ AVP of Advocacy & Compliance discusses industry challenges, special initiatives, and more in a video spotlight.

Read More →
Medmonitor
FDA Approves Diazepam Nasal Spray and Fast Tracks New Drug for Spinal Cord Injury

A new seizure drug has been approved, and a nerve growth drug advances in clinical trials.

Read More →
This Month's Must Read
4 Regulatory Trends to Watch Out for in 2020

What will 2020 hold for marijuana acceptance, employee misclassification, formularies, and AI?

Read More →
Clinical Insights
WCIRB Publishes Physical Medicine Report

An analysis of 1.5 million claims found early physical therapy lowers odds of opioid use by 14%.

Read More →
Legislation & Policy
Marijuana Bills Could Create Protections for Employment Discrimination

Testing positive for marijuana use could one day no longer prohibit employment.

Read More →
Opioid Developments
An Opioid Snapshot for 2020

With a flurry of opioid developments lately, what does the big picture look like?

Read More →
Medmonitor
Three Drug Approvals and a Safety Warning

Migraine, arthritis, and insomnia drug approvals, and a gabapentinoids safety warning.

Read More →
Clinical Insights
Psilocybin for Mental Health Disorders?

Does the active ingredient in magic mushrooms have a future in mental health?

Read More →
Clinical Insights
MDMA Gains Steam for PTSD Treatment

Phase 3 studies are underway, and current research sees potential for MDMA in psychotherapy.

Read More →
Clinical Insights
Lavender Administration Shows Promise for Anxiety

A recent meta-analysis of over 100 trials and studies found lavender to significantly reduce anxiety levels.

Read More →
Medmonitor
New Drug Developments Impacting Comp

A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.

Read More →
This Month's Must Read
Questioning Costs: A Field Guide to Fee Schedules

Understand how prices are set for medical equipment and services, and how to scrutinize those costs.

Read More →
Clinical Insights
How Declining Opioid Use Impacts Claims and Outcomes

According to the CWCI, reduced opioid utilization from 2010-2017 saved $6.5 billion in California comp costs.

Read More →
Legislation & Policy
Minnesota Proposes PTSD Treatment Guidelines

Beyond compensability, Minnesota considers rules for evaluation, treatment planning, acceptable psychotherapies, and more.

Read More →
Healthe Developments
Healthe in the Media

Workers’ comp publications cover Healthesystems content surrounding aging physicians, successful return-to-work programs, and more.

Read More →
Medmonitor
Recalls Impacting Workers’ Comp

A previous gastrointestinal drug recall expands, while a new recall for an anxiety drug is issued.

Read More →
Clinical Insights
HHS Publishes Opioid Tapering and Discontinuation Guideline

The guideline covers a wide range of relevant topics, including pain, dosing, dangerous co-prescribing, comorbidities, and more.

Read More →
Legislation & Policy
More States Scrutinize Gig Economy Classifications

Shortly after California made strides on employee classification for gig economy jobs, New Jersey and New York have taken action.

Read More →
Opioid Developments
The Economic Impact of Non-Medical Opioid Use

The Society of Actuaries published a report that claims the economic burden of the opioid epidemic was $631 billion from 2015-2018.

Read More →
Medmonitor
Multiple Companies Recall Ranitidine Hydrochloride Due to Contamination

Indicated for various gastrointestinal concerns, these recalls could impact certain workers’ comp patients.

Read More →
Clinical Insights
Social Determinants of Health

PwC explores how social factors impact chronic health conditions.

Read More →
Legislation & Policy
California Gig Law to Reclassify Contractors as Employees

This reclassification will entitle millions of workers to benefits previously withheld, including workers’ comp.

Read More →
Healthe Developments
Healthesystems at NWCDC 2019

Join Healthesystems at booth #1922, at an educational presentation, or by taking our industry survey with Risk & Insurance.

Read More →
Medmonitor
FDA Postpones Opioid Approval Decision

NKTR-181 (loxicodegol) was to receive an approval decision by August 29th, but a reevaluation of opioid policy has resulted in a delay.

Read More →
This Month's Must Read
Robert Goldberg and Silvia Sacalis Discuss Workplace Fatigue with Risk & Insurance

Healthesystems’ clinical leaders speak to mitigation strategies to reduce workplace injuries stemming from fatigue.

Read More →
Clinical Insights
California Publishes One-Year Report on Workers’ Comp Formulary

The utilization of opioids, compounds, and physician-dispensed medications have significantly decreased.

Read More →
Legislation & Policy
DEA to Improve Access to Marijuana Research

Proposed changes to who can grow and research marijuana will soon be available for public commentary.

Read More →
Opioid Developments
Johnson & Johnson to Pay $572 Million in Opioid Trial

An Oklahoma judge found the drug maker to be partially responsible for the harm of the opioid epidemic.

Read More →
Healthe Developments
Three Insights from WOHC 2019

Healthesystems’ Chief Medical Officer explores trends impacting workers’ comp, including patient engagement, population health, and more.

Read More →
Medmonitor
FDA Approves First Lyrica Generics

Nine generic versions of Lyrica (pregabalin) have been approved for the treatment of five different medical conditions.

Read More →
Spotlight
Healthesystems AVP of Advocacy & Compliance Named Finalist for Comp Laude Award

Sandy Shtab has been recognized for making significant contributions to the workers’ comp industry.

Read More →
Clinical Insights
FAIR Health Publishes Telemedicine Report

Looking at over 29 billion private health claims, this study found that claim lines related to telehealth rose 624% from 2014-2018.

Read More →
Opioid Developments
WCRI Reports on Interstate Variation in Dispensing Opioids

While many states report fewer opioid prescriptions, MME levels vary more significantly by state.

Read More →
Innovation
Will Autonomous Vehicles Impact Workers’ Comp?

NCCI estimates that a 25-75% reduction in motor vehicle accidents in workers’ comp could save $1-4 billion, creating interest in self-driving cars.

Read More →
Medmonitor
First-Time Generics Approved for Two Pain Medications

Generic versions of Ultram (tramadol hydrochloride) tablets and Dyloject (diclofenac sodium) injections have been approved by the FDA.

Read More →
Clinical Insights
NCCI Examines Impact of the ODG Formulary in Arizona and Tennessee

While the utilization of opioids and other problematic drugs decreased, similar drops were seen in states without closed formularies.

Read More →

Workers’ Comprehensive

News and views in workers’ comp
Important news in workers’ comp delivered to your inbox
Subscribe
Back to Top
lockenvelopephone-handsetmagnifiercrossmenucross-circle